Invicta Diagnostic IPO Details
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹80 to ₹85 Per Share |
| Issue Size | Approx ₹28.12 Crores |
| Fresh Issue | Approx ₹28.12 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Invicta Diagnostic IPO Review & Key Points
- Review: Neutral
- Rating: 2
Invicta Diagnostic IPO Market Lot
The Invicta Diagnostic IPO minimum market lot is 3,200 shares with ₹2,72,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 3,200 | ₹2,72,000 |
| Retail Maximum | 2 | 3,200 | ₹2,72,000 |
| S-HNI Minimum | 3 | 4,800 | ₹4,08,000 |
| S-HNI Maximum | 7 | 11,200 | ₹9,52,000 |
| B-HNI Minimum | 8 | 12,800 | ₹10,88,000 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 7,98,400 Shares | 24.13% |
| QIB (Ex. Anchor) | 5,34,400 Shares | 16.15% |
| NII Shares Offered | 5,42,400 Shares | 16.39% |
| Retail Shares Offered | 12,67,200 Shares | 38.30% |
Invicta Diagnostic IPO Anchor Investors
| Anchor Bidding Date | November 28, 2025 |
| Anchor Investors List | |
| Shares Offered | 7,98,400 Shares |
| Anchor Size | 6.79 Cr. |
| lock-in period end date 50% shares (30 Days) | January 4, 2025 |
| lock-in period end date 50% shares (90 Days) | March 3, 2025 |
Invicta Diagnostic IPO Dates
The Invicta Diagnostic IPO date is December 1 and the close date is December 3. The Invicta Diagnostic IPO allotment will be finalized on December 4 and the IPO listing on December 8.
| IPO Open Date: | December 1, 2025 |
| IPO Close Date: | December 3, 2025 |
| Basis of Allotment: | December 4, 2025 |
| Refunds: | December 5, 2025 |
| Credit to Demat Account: | December 5, 2025 |
| IPO Listing Date: | December 8, 2025 |
| IPO Bidding Cut-off Time: | December 3, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi and Jayesh Prakash Jain.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 92,63,173 | 91.89% |
| Promoter Holding Post Issue | 1,25,71,973 | -% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra; and | ₹21.11 |
| General Corporate Purpose | ₹- |
About Invicta Diagnostic IPO
Invicta Diagnostic Limited has been engaged in providing radiology and pathology solutions since January 2021. Under the brand ‘PC Diagnostics’, the company provides pathology and radiology tests, including imaging and teleradiology. Invicta runs 7 diagnostic centres and a central lab across Mumbai, Maharashtra. As of October 31, 2025, the company provides a wide range of medical specialty tests, including 60 routine and 487 specialized pathology tests, along with 96 basic and 130 advanced radiology tests.
The company offers a wide range of pathology and radiology tests, such as biochemistry and clinical pathology, cytogenetics, and high-end molecular diagnostics, basic echocardiograms, X-rays, ultrasounds, CT scans, MRI scans, and PET CT scans. Moreover, the company also runs a hub-and-spoke model in the Mumbai Metropolitan Region with a main hub in Thane West, 3 additional hubs in Bhayandar, Byculla, and Marol, and 3 spokes in Lower Parel, Sewri, and Kalwa.
Invicta Diagnostic IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2024 | ₹15.90 | ₹10.78 | ₹3.81 | ₹15.89 |
| 2025 | ₹30.18 | ₹23.62 | ₹4.93 | ₹21.22 |
| September 2025 | ₹17.08 | ₹11.65 | ₹4.08 | ₹34.90 |
Invicta Diagnostic IPO Valuation – FY2025
Check Invicta Diagnostic IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 44.28% |
| ROCE: | 42.00% |
| EBITDA Margin: | 30.57% |
| PAT Margin: | 16.38% |
| Debt to equity ratio: | 0.26 |
| Earning Per Share (EPS): | ₹5.86 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 36.25% |
| Net Asset Value (NAV): | ₹16.15 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Vijaya Diagnostic Centre Limited | 13.95 | 71.90 | 17.99% | 77.86 | – Cr. |
| Krsnaa Diagnostics Limited | 24.04 | 29.58 | 8.79% | 272.54 | – Cr. |
IPO Lead Managers aka Merchant Bankers
- Socradamus Capital Pvt. Ltd.
Company Address
Invicta Diagnostic Ltd.
1 GF, Plot 217, Ambavat Bhavan
N.M Joshi Marg
Delisle Road
Mumbai, Maharashtra, 400013
Phone: 022 – 4971 0036
Email: [email protected]
Website: https://www.pcdiagnostics.in/
IPO Registrar
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/IPO_Status.html
Invicta Diagnostic IPO FAQs
What is Invicta Diagnostic IPO?
When Invicta Diagnostic IPO will open for subscription?
What is Invicta Diagnostic IPO Investors Portion?
How to Apply the Invicta Diagnostic IPO?
What is Invicta Diagnostic IPO Issue Size?
What is Invicta Diagnostic IPO Price Band?
What is Invicta Diagnostic IPO Lot Size?
What is the Invicta Diagnostic IPO Allotment Date?
What is the Invicta Diagnostic IPO Listing Date?
Note: The Invicta Diagnostic IPO price band and date are officially announced. The (Invicta Diagnostic IPO grey market premium) will be added to the IPO GMP page as it will start).
